Revenue | ₹14.14Cr |
Net Profits | ₹0.33Cr |
Net Profit Margins | 2.33% |
Sandu Pharmaceuticals Ltd’s revenue fell -11.13% since last year same period to ₹14.14Cr in the Q4 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -23.15% fall in its revenue since last 3-months.
Sandu Pharmaceuticals Ltd’s net profit fell -44.07% since last year same period to ₹0.33Cr in the Q4 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -41.07% fall in its net profits since last 3-months.
Sandu Pharmaceuticals Ltd’s net profit margin fell -37.07% since last year same period to 2.33% in the Q4 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -23.32% fall in its net profit margins since last 3-months.
The revenue for Sandu Pharmaceuticals Ltd in the Q4 results 2024 was ₹14.14Cr.
The net profit for Sandu Pharmaceuticals Ltd in the Q4 results 2024 was ₹0.33Cr.
The net profit margin for Sandu Pharmaceuticals Ltd in the Q4 results 2024 was 2.33%.
The revenue for Sandu Pharmaceuticals Ltd in the Q4 results 2023 was ₹15.91Cr.
The net profit for Sandu Pharmaceuticals Ltd in the Q4 results 2023 was ₹0.59Cr.
The net profit margin for Sandu Pharmaceuticals Ltd in the Q4 results 2023 was 3.71%.